搜尋結果
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 11 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Weight loss drug contender Zealand Pharma jumps 18% on trial results
CNBC· 21 小時前... popped on Friday, notching a record high after an early-stage study of its weight ... ...
The 8 Best Wet Cat Foods To Keep Your Pet Healthy And Hydrated
Forbes· 5 日前Whether your cat isn’t a fan of dry kibble or they don’t drink enough water, incorporating wet food into their diet can ...
Indian shares pare gains as slide in banks outweighs IT uptick
Reuters· 1 日前Indian shares surrendered early gains on Friday, as a decline in banks outweighed the rise in ...
How Long Can Extreme Concentration Last?
Forbes· 1 日前It has been a good year for the large capitalization market averages. The S&P 500 is up about 14% so far this year. Furthermore ...
Ron Insana: Never mind the narrow leadership. This is a powerful bull market
CNBC· 11 小時前There has been a fair amount of nervous chatter lately about the state of the stock market. ...
NRG Energy Shares Are Powered Up
Forbes· 1 日前As such, the GuruFocus All-in-One Screener, a Premium feature, found some stocks within this space are outperforming the ...
S&P 500 to break above 5,700 in the second half of 2024, Ned Davis Research says
CNBC· 15 小時前The new target suggests that the broad market index can rise more than 4% from its current ...
Robert Whittaker vs Ikram Aliskerov Prediction: Ex-Champ is Still a Menace
telecomasia.net· 11 小時前The card will be kicked off by the fight between Robert Whittaker and Ikram Aliskerov, with the ...
Wall St Week Ahead Rally in U.S. big tech stocks may be getting stretched
Reuters· 11 小時前A blistering rally in U.S. big tech stocks may be due for a breather, offering hope for market ...